Pancreatic Cancer Research

ResearcherAlfaisal UniversityActive in the last 2 years

Ehab Takrori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0009-9062-9761; OpenAlex author ID A5119042978. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2025: 1 paper · 2026: 4 papers

Papers 5

  1. Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. First author DOI 10.3389/fonc.2026.1901721↗
  2. Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. First author DOI 10.3389/fonc.2026.1955091↗
  3. Advances in KRAS-Targeted Therapies for Pancreatic Cancer. Co-author DOI 10.3390/cancers18182961↗
  4. Recent Advances in Pancreatic Cancer and Biliary Tract Cancers: Biology, Biomarkers, and Evolving Systemic Therapy. Co-author DOI 10.3390/ijms27104413↗
  5. Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies. First author DOI 10.3390/ijms26157055↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Supriya Peshin · 5 shared papers, 2025–2026 · strength 1.64
  2. Shafia Rahman · 3 shared papers, 2026 · strength 1.02
  3. Harrison Kim · 2 shared papers, 2026 · strength 0.63
  4. Mark P. Rubinstein · 2 shared papers, 2026 · strength 0.63
  5. Sakshi Singal · 2 shared papers, 2025–2026 · strength 0.62

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.